[Update] Previously covered: 2026-03-30, MRR change: +25.6%
Telehealth / Weight Management — Online GLP-1 medication prescribing platform. The segment has seen explosive growth driven by the Ozempic boom.
TrimRx: A telehealth company focused on GLP-1 weight loss, founded by Cris, MRR $338,096.
TrimRx grew MRR by +25.6% in just 11 days — the strongest growth signal this period. The GLP-1 boom continues, but regulatory risk and competition from major players (Hims $200M+) warrant caution. Adjacent SaaS tools (patient management, drug tracking, remote follow-up) may be the entry point for non-medical founders.
Members unlock all in-depth reports and weekly curated business intelligence